Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 34 Show results per page	View Search Criteria \| Help With Results


1.		Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial of Two Dose Levels of AZT in the Treatment of Human Immunodeficiency Virus Infection in Patients with AIDS-Associated Kaposi's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Closed				18 and over				NIAID				NIAID-ATEU-001 NCI-V86-0151

Last Modified: 1/26/2004


2.		Phase III Randomized Study of Dose-Intensity in G-CSF-Supported Treatment of AIDS-Related Lymphoma: ACVB (DOX/CTX/DAVA/BLEO/PRDL) vs CHOP (CTX/DOX/VCR/PRDL) for Low Risk, CHOP vs Low-Dose CHOP for Medium Risk, and Low-Dose CHOP vs VCR/PRDL for High Risk (Summary Last Modified 11/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								EORTC-70931

Last Modified: 9/1/1988


3.		Phase I/II Evaluation of DM/MTX/CF plus Cranial Irradiation plus AZT for AIDS-Related Primary CNS Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Closed				18 to 70				NIAID				NIAID-ATEU-009 NCI-V87-0223

Last Modified: 4/1/1988


4.		Phase I/II Trial of AZT/IFN-alpha in AIDS Patients with Kaposi's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Closed				18 to 60				NIAID				NIAID-87-I-32 NCI-V87-0232

Last Modified: 7/1/1991


5.		Phase I/II Study of FLAP (5-FU/LV/AZT/DP) in Patients with Metastatic Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				BRMP-8916C NCI-90-C-45C, NCI-T89-0135N, T89-0135

Last Modified: 6/1/1990


6.		Phase I/II Pilot Study of Cytotoxic Chemotherapy with CTX/DOX/VP-16/VCR/MTX/CF plus Recombinant GM-CSF, AZT, and Inhaled Pentamidine in Patients with AIDS-Associated non-Hodgkin's Lymphoma (Summary Last Modified 06/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				NCI-90-C-34 NCI-MB-249, NCI-T89-0194N, T89-0194

Last Modified: 7/1/1992


7.		Phase I/II Study of CTX/VCR/DOX/VP-16 with ddI, G-CSF, and CNS Prophylaxis/Therapy in Patients with AIDS-Associated non-Hodgkin's Lymphoma (Summary Last Modified 07/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				NCI-92-C-0162 NCI-T92-0039N, T92-0039

Last Modified: 6/1/1999


8.		Phase II Study of ZDV/IFN-A in Patients with HTLV-I-Associated Adult T-Cell Leukemia/Lymphoma (Summary Last Modified 06/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				NCI-94-C-0070F NCI-T93-0149N, T93-0149

Last Modified: 1/1/1998


9.		Phase II Study of IFN-A/13-CRA for Invasive Cervical Carcinoma in HIV-Positive Women, with ZDV for Low CD4 Counts (Summary Last Modified 01/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				GOG-155

Last Modified: 12/1/2000


10.		Phase II Study of Etoposide/Mitoxantrone/Prednimustine for Relapsed Disease and Cyclophosphamide/Doxorubicin/Etoposide for Refractory Disease in Patients with HIV-Associated non-Hodgkin's Lymphoma (Summary Last Modified 12/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								ITA-GICAT-C/941202-3 EU-96059, NCT00002905

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute